Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 28, 2016; 22(16): 4226-4237
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4226
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4226
Figure 2 Effect of eEF1A2-shRNA on eEF1A2 expression in BEL-7402 cells (n = 3).
GAPDH was used as an internal control. A: Relative expression of eEF1A2 mRNA; B: eEF1A2 protein levels as detected by the Western blot method (upper, Western blot; lower, quantification of Western blot normalized by GADPH). Data are mean ± SD (n = 3). bP < 0.01 vs NC and CON. CON: Blank control group not infected; NC: Negative control group infected with GV115-LV; KD: eEF1A2 RNAi group infected with GV115-eEF1A2-shRNA-LV.
- Citation: Qiu FN, Huang Y, Chen DY, Li F, Wu YA, Wu WB, Huang XL. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling. World J Gastroenterol 2016; 22(16): 4226-4237
- URL: https://www.wjgnet.com/1007-9327/full/v22/i16/4226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i16.4226